Excessive Daytime Sleepiness
Pipeline by Development Stage
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Clinical Trials (4)
Total enrollment: 1,442 patients across 4 trials
Study to Assess Patient Reported Outcomes With Armodafinil Treatment for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome
Extension Study of the Safety and Efficacy of Armodafinil in the Treatment of Patients With Excessive Sleepiness
BEN-2001 in Parkinson Disease Patients With Excessive Daytime Sleepiness
A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of Age
Related Jobs
Specialty Account Manager, Auvelity (Los Angeles, CA)
Regional Business Director, Symbravo (Ohio - Michigan Region)
Specialty Account Manager, Symbravo (Minneapolis, MN)
Specialty Account Manager, Symbravo (Brooklyn E, NY)
Regional Business Director, Auvelity (Milwaukee, WI)
Specialty Account Manager, Auvelity (Fort Smith, AR)
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.